Electrophysiology Devices Market
According to Intent Market Research, the Electrophysiology Devices Market is expected to grow from USD 7.2 billion in 2023 at a CAGR of 2.6% to touch USD 8.6 billion by 2030. The Electrophysiology Devices Market is dominated by key players such as Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Johnson & Johnson (Biosense Webster), Siemens Healthineers, GE Healthcare, Biotronik, MicroPort Scientific Corporation, Hill-Rom Holdings, Inc., Stryker Corporation, AtriCure, Inc., Invivo Corporation, Cardiome Pharma Corporation.